Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 46

1.

Medical management of adult headache.

Freitag FG, Schloemer F.

Otolaryngol Clin North Am. 2014 Apr;47(2):221-37. doi: 10.1016/j.otc.2013.11.002. Epub 2013 Dec 19. Review.

PMID:
24680490
2.

[Predictive factors of the response to treatment with onabotulinumtoxinA in refractory migraine].

Pagola I, Esteve-Belloch P, Palma JA, Luquin MR, Riverol M, Martinez-Vila E, Irimia P.

Rev Neurol. 2014 Mar 16;58(6):241-6. Spanish.

3.

Botulinum toxin A and headache treatment.

Gady J, Ferneini EM.

Conn Med. 2013 Mar;77(3):165-6. Review.

PMID:
23589955
4.

Managing and treating tension-type headache.

Freitag F.

Med Clin North Am. 2013 Mar;97(2):281-92. doi: 10.1016/j.mcna.2012.12.003. Epub 2012 Dec 27. Review.

PMID:
23419626
5.

Botulinum toxin A for prophylactic treatment of migraine and tension headaches in adults: a meta-analysis.

Jackson JL, Kuriyama A, Hayashino Y.

JAMA. 2012 Apr 25;307(16):1736-45. doi: 10.1001/jama.2012.505.

PMID:
22535858
6.

Application of botulinum toxin to clinical therapy: advances and cautions.

Levy NS, Lowenthal DT.

Am J Ther. 2012 Jul;19(4):281-6. doi: 10.1097/MJT.0b013e3181e9b655.

PMID:
22481607
7.

Botox treatment for migraine and chronic daily headache in adolescents.

Chan VW, McCabe EJ, MacGregor DL.

J Neurosci Nurs. 2009 Oct;41(5):235-43.

PMID:
19835236
8.

Assessment: botulinum neurotoxin in the treatment of autonomic disorders and pain (an evidence-based review): report of the therapeutics and technology assessment subcommittee of the american academy of neurology.

Mauskop A, Mathew N.

Neurology. 2009 Apr 14;72(15):1367; author reply 1367-8. doi: 10.1212/WNL.0b013e3181a53375. No abstract available. Erratum in: Neurology. 2009 Aug 18;73(7):573.

PMID:
19365063
9.

Botulinum toxin type-A (BOTOX) in the treatment of occipital neuralgia: a pilot study.

Taylor M, Silva S, Cottrell C.

Headache. 2008 Nov-Dec;48(10):1476-81. doi: 10.1111/j.1526-4610.2008.01089.x.

PMID:
19076646
10.

[Alternatives to beta blockers in preventive migraine treatment].

Evers S.

Nervenarzt. 2008 Oct;79(10):1135-6, 1138-40, 1142-3. doi: 10.1007/s00115-008-2522-2. Review. German.

PMID:
18806984
11.

Treating headaches with botulinum toxin.

Aguggia M.

Neurol Sci. 2008 May;29 Suppl 1:S137-9. doi: 10.1007/s10072-008-0905-6. Review.

PMID:
18545915
12.
13.

Botulinum toxin type A for the treatment of headache: why we say yes.

Ashkenazi A, Silberstein S.

Arch Neurol. 2008 Jan;65(1):146-9. doi: 10.1001/archneurol.2007.20. Review. No abstract available.

PMID:
18195155
14.
15.

Botulinum toxin type A for the treatment of nummular headache: four case studies.

Mathew NT, Kailasam J, Meadors L.

Headache. 2008 Mar;48(3):442-7. Epub 2007 Nov 20.

PMID:
18028377
16.

Evidence based medicine on the use of botulinum toxin for headache disorders.

Schulte-Mattler WJ, Leinisch E.

J Neural Transm. 2008;115(4):647-51. Epub 2007 Nov 12. Review.

PMID:
17994180
17.

Botulinum toxin type A in refractory chronic migraine: an open-label trial.

Menezes C, Rodrigues B, Magalhães E, Melo A.

Arq Neuropsiquiatr. 2007 Sep;65(3A):596-8.

18.

Predictors of response to botulinum toxin type A (BoNTA) in chronic daily headache.

Mathew NT, Kailasam J, Meadors L.

Headache. 2008 Feb;48(2):194-200. Epub 2007 Sep 12.

PMID:
17868356
19.

Botulinum toxin type A in chronic migraine.

Freitag FG.

Expert Rev Neurother. 2007 May;7(5):463-70. Review.

PMID:
17492897
20.

BOTOX for headache treatment.

Rothrock JF.

Headache. 2007 Feb;47(2):345-6. No abstract available.

PMID:
17300388
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk